GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzolytics Inc (OTCPK:ENZC) » Definitions » Gross Profit

Enzolytics (Enzolytics) Gross Profit : $0.05 Mil (TTM As of Jun. 2011)


View and export this data going back to 2008. Start your Free Trial

What is Enzolytics Gross Profit?

Enzolytics's gross profit for the three months ended in Jun. 2011 was $0.02 Mil. Enzolytics's gross profit for the trailing twelve months (TTM) ended in Jun. 2011 was $0.05 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Enzolytics's gross profit for the three months ended in Jun. 2011 was $0.02 Mil. Enzolytics's Revenue for the three months ended in Jun. 2011 was $0.02 Mil. Therefore, Enzolytics's Gross Margin % for the quarter that ended in Jun. 2011 was N/A%.

Enzolytics had a gross margin of N/A% for the quarter that ended in Jun. 2011 => No sustainable competitive advantage


Enzolytics Gross Profit Historical Data

The historical data trend for Enzolytics's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzolytics Gross Profit Chart

Enzolytics Annual Data
Trend Dec07 Jul08 Dec09 Dec10
Gross Profit
- - 0.02 0.04

Enzolytics Quarterly Data
Sep07 Dec07 Apr08 Jul08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.02

Competitive Comparison of Enzolytics's Gross Profit

For the Biotechnology subindustry, Enzolytics's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzolytics's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enzolytics's Gross Profit distribution charts can be found below:

* The bar in red indicates where Enzolytics's Gross Profit falls into.



Enzolytics Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Enzolytics's Gross Profit for the fiscal year that ended in Dec. 2010 is calculated as

Gross Profit (A: Dec. 2010 )=Revenue - Cost of Goods Sold
=0.037 - 0
=0.04

Enzolytics's Gross Profit for the quarter that ended in Jun. 2011 is calculated as

Gross Profit (Q: Jun. 2011 )=Revenue - Cost of Goods Sold
=0.015 - 0
=0.02

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Enzolytics's Gross Margin % for the quarter that ended in Jun. 2011 is calculated as

Gross Margin % (Q: Jun. 2011 )=Gross Profit (Q: Jun. 2011 ) / Revenue (Q: Jun. 2011 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.02 / 0.015
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Enzolytics  (OTCPK:ENZC) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Enzolytics had a gross margin of N/A% for the quarter that ended in Jun. 2011 => No sustainable competitive advantage


Enzolytics Gross Profit Related Terms

Thank you for viewing the detailed overview of Enzolytics's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzolytics (Enzolytics) Business Description

Traded in Other Exchanges
N/A
Address
1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013
Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: Immunotherapy, immune modulators, fully human monoclonal antibodies, and an artificial intelligence (AI) platform for health care developments. It has clinically tested anti-HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus.

Enzolytics (Enzolytics) Headlines

From GuruFocus

Enzolytics to Develop Feline Monoclonal Antibodies

By ACCESSWIRE ACCESSWIRE 01-03-2023